Jeffrey Thomas Bagdanoff from East Weymouth, MA, age 47

Aminoheteroaryl Benzamides As Kinase Inhibitors
view source
US Patent:

20170182038, Jun 29, 2017
Filed:

Dec 9, 2015
Appl. No.:

14/964057
Inventors:

Jeffrey T. BAGDANOFF - North Reading MA, US
Yu DING - Union City CA, US
Wooseok HAN - San Ramon CA, US
Zilin HUANG - Foster City CA, US
Qun JIANG - Suzhou city, JP
Xianming JIN - San Ramon CA, US
Xiang KOU - Shanghai, CN
Patrick LEE - Walnut Creek CA, US
Mika LINDVALL - Oakland CA, US
Zhongcheng MIN - Shouzhou/ Jiangsu Province, CN
Yue PAN - Lexington MA, US
Sabina PECCHI - Oakland CA, US
Keith Bruce PFISTER - San Ramon CA, US
Daniel POON - Piedmont CA, US
Vivek RAUNIYAR - Cambridge MA, US
Xiaojing Michael WANG - Livermore CA, US
Qiong ZHANG - Shanghai, CN
Jianguang ZHOU - Shanghai, CN
Shejin ZHU - Dublin CA, US
Assignee:

Novartis AG - Basel
International Classification:

A61K 31/497
A61K 31/5355
A61K 31/4436
A61K 31/4433
A61K 31/44
Abstract:

The present invention provides a compound of Formula (I) or a salt thereof;and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.

Aminoheteroaryl Benzamides As Kinase Inhibitors
view source
US Patent:

20150126490, May 7, 2015
Filed:

Oct 29, 2014
Appl. No.:

14/527328
Inventors:

Jeffrey T. BAGDANOFF - North Reading MA, US
Yu DING - Union City CA, US
Wooseok HAN - San Ramon CA, US
Zilin HUANG - Foster City CA, US
Qun JIANG - Suzhou city, CN
Jeff Xianming JIN - San Ramon CA, US
Xiang KOU - Shanghai, CN
Patrick LEE - Walnut Creek CA, US
Mika LINDVALL - Oakland CA, US
Zhongcheng MIN - Shouzhou, CN
Yue PAN - Lexington MA, US
Sabina PECCHI - Oakland CA, US
Keith Bruce PFISTER - San Ramon CA, US
Daniel POON - Piedmont CA, US
Vivek RAUNIYAR - Cambridge MA, US
Xiaojing Michael WANG - Livermore CA, US
Qiong ZHANG - Shanghai, CN
Jianguang ZHOU - Shanghai, CN
Shejin ZHU - Dublin CA, US
Assignee:

Novartis AG - Basel
International Classification:

C07D 498/04
A61K 31/497
A61K 45/06
C07D 401/04
A61K 31/4545
C07D 405/14
A61K 31/506
C07D 409/04
A61K 31/4436
A61K 31/5383
C07D 241/20
A61K 31/4965
A61K 31/4439
C07D 413/14
A61K 31/5377
A61K 31/553
C07D 405/04
US Classification:

51421018, 544336, 51425505, 546194, 514318, 544333, 514256, 5462804, 514336, 544105, 5142305, 51425506, 5462784, 514343, 544131, 5142355, 540490, 51421105
Abstract:

The present invention provides a compound of Formula (I) or a salt thereof;and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.